SDGs+Beyond Future Society for Life Week
World Cancer Eradication Summit in EXPO 2025
World Cancer Eradication Summit 2025 executive committee
Cancer is now a common disease for the mankind that threatens the life.
In this program, we will work around the world to eradicate cancer and find a way to free mankind.
Indeed, we will look at the cutting-edge medicine without conventional thoughts, and discuss “What should we do to realize a society in which people can live healthy and brightly until the end of lives?”
Recorded video available
Discussion
- life
- future society
- Society 5.0
| Transmission of simultaneous interpretation | Provided |
|---|---|
| Language of interpretation | Japanese and English |
-
Agenda2025
Participation Programme
- Time and
Date of
the event -
-
2025.10.05[Sun]
14:30 ～ 16:30
(Venue Open 14:00)
-
- Venue
- Theme Weeks Studio
Highlights
00:05:57 Opening Ceremony: Mr. Masafumi Mori, Assistant to the Prime Minister (Reading a congratulatory message on behalf of Prime Minister Shigeru Ishiba) Greetings from Mr. Hirofumi Yoshimura, Governor of Osaka Prefecture, and others.
00:18:27 Keynote Lecture: “Unlocking the Potential of Omura Natural Products in Drug Discovery” by Dr. Toshiaki Sunazuka, President of Kitasato University.
00:39:49 Talk Session: “ Future Strategies for Cancer Eradication”
Programme details
*Subtitles: Choose “Subtitles/CC” in the “Settings” (gear icon) at the bottom right of the YouTube video.
*Subtitles may not show with multiple languages or overlapping audio.
In 1961, U.S. President John F. Kennedy called for “a new frontier,” mankind was able to stand on the Moon. Thus, even a single proposer can realize the “New Frontier”. The momentum continues to the present in the 21st century. The scientific and technological benefits that humanity has enjoyed during this period are immeasurable.
On the other hand, there exists another “new frontier” on the earth. In 2022, President Biden also proposed a vision for the eradication of cancer, following 10 years of work together by volunteers in Japan and the Government of Japan since 2015. “Cancer Eradication” is now one of the themes for building a sustainable future for ”the society where life shines brightly”.
The program discusses cutting-edge biotechnologies and innovations needed to move from “conquering cancer” to “eradicating cancer,” as well as the economic environment that will support these efforts. The program brings together Nobel laureates and researchers in cutting-edge medicine from Japan and abroad, as well as experts representing industry, government, and academia. This summit is designing a vision for the future in a cross-discussion.
Reports
【Reflection】
The summit consisted of four parts: guest addresses, a keynote lecture, a talk session, and a declaration announcement.
To begin, the guest address featured then-Special Advisor to the Prime Minister, Mr. Masafumi Mori, and Governor of Osaka Prefecture, Mr. Hirofumi Yoshimura, who spoke about the current state and challenges of medical policy, as well as their hopes for cancer eradication.
In the keynote lecture, Dr. Toshiaki Sunazuka, President of Kitasato University, explained the importance of natural product drug discovery. He particularly highlighted the potential of ivermectin to reduce side effects when used in combination with anticancer drugs, offering a new perspective for future clinical applications.
The main talk session, themed “What is the Future Strategy for Cancer Eradication?”, featured discussions on personalized medicine, AI utilization, and innovations in clinical trials.
Professor Mark J. Ratain of the University of Chicago presented research findings on the effectiveness and reduced side effects of low-dose chemotherapy, emphasizing the need for optimal treatment tailored to each patient. Professor Chak-Sing Lau, Vice-President of the University of Hong Kong, introduced Hong Kong’s practical systems for prevention and diagnosis, including the utilization of long-term medical data through the development of electronic health records and the adoption of AI-based imaging diagnostic technologies.
Dr. Sujuan Ba, Chair of the National Foundation for Cancer Research (NFCR), pointed out that more than half of the world’s cancer patients are concentrated in Asia. She stressed the need for international expansion and improved efficiency in clinical trials through the introduction of the innovative “GBM Agile” trial framework.
Through these discussions, participants shared the understanding that medical progress requires not only scientific and technological advancements but also collaboration with political and administrative sectors. The summit chair, Prof. George Hara, advocated for healthcare system reform based on the principles of public interest capitalism and emphasized the importance of creating a societal framework for tackling cancer eradication.
In conclusion, a shared recognition emerged among participants that “cancer eradication is not a national issue, but one that can only be achieved through international cooperation.” The summit concluded with the announcement of the “World Cancer Eradication: Osaka-Kansai Expo Declaration 2025” was announced.
Through this summit, the sharing of concrete research findings by experts deepened participants' understanding and demonstrated the potential for collaboration among government, industry, and research institutions. We recognize that this has laid the groundwork for future policy development and discussions on healthcare system reform.
Furthermore, we observed heightened interest in advanced medical technologies, such as personalized cancer treatment and AI utilization, along with a growing enthusiasm among participants for practical applications.
We believe understanding of the international clinical trial framework has advanced, clarifying the role Japan should play as a hub in Asia.
【Post EXPO Initiatives】
After the summit, we will compile the insights and perspectives shared by leading medical doctors and researchers from around the world and apply them to our future initiatives, with the aim of benefiting as many cancer patients as possible. We will also strive to further strengthen global collaboration and raise awareness of cutting-edge efforts toward the eradication of cancer—not only in Japan, but around the world.
At the summit, key topics included alleviating the pain and burden on patients, strategic cancer prevention and early detection, and the rapid delivery of promising treatments to those in need. These discussions also brought to light underlying challenges such as the high cost of anti-cancer drugs, the need for greater investment in research and education, and issues within the drug approval system.
Addressing these challenges is essential to realizing the theme of Expo 2025, “Designing Future Society for Our Lives,” as well as the vision advocated by the chairman, Prof. George Hara: “a society in which all citizens remain healthy until just before fulfilling their natural lifespan.”
Moving forward, we will continue working in partnership with the co-organizer, the Alliance Forum Foundation, to build and institutionalize fair systems and frameworks that ensure equitable access for all. Our goal is to swiftly deliver medical care, advanced technologies, and vital information to every patient in need, further advancing cancer treatment and its integration into society—and ultimately accelerating our efforts toward the eradication of cancer.
Cast
Moderator
Amb. George HARA
Alliance Forum Foundation
Ambassador Hara has been working for over 40 years to create a world made up of a healthy and educated middle class. To achieve this goal, he has worked hard at various positions, including Special Advisor to the Cabinet Office of the Japanese Government, Special Advisor to the Ministry of Finance, Honorary Co-Chairman of the Republican Business Advisory Council, Special Envoy to the United Nations Intergovernmental Organizations, and Advisor to the President of Zambia. Additionally, in his efforts to eradicate cancer, he has served as a professor at the medical schools of the Chinese University of Hong Kong, Osaka University, and Osaka City University.
View Profile
Close
close
Speakers
Dr. Toshiaki Sunazuka
Kitasato University
Professor Toshiaki Sunazuka is the president of Kitasato University, Specially Appointed Professor at the Omura Satoshi Memorial Institute, Kitasato University, and a member of the board of directors of the Kitasato Institute. He is a leader in both education and research. As the successor to Professor Satoshi Omura, a 2015 Nobel Prize laureate in Physiology or Medicine, and Distinguished Honorary Professor at Kitasato University, Prof. Sunazuka is conducting research on “Microbial Drug Discovery.”
View Profile
Close
close
Dr. Sujuan Ba
National Foundation for Cancer Research：NFCR
Dr. Ba is the President and Chief Executive Officer (CEO) of the National Foundation for Cancer Research (NFCR). This influential foundation provides funding for high-impact and high-risk cancer research projects. Dr. Ba is an internationally recognized leader in cancer research, promoting scientific innovation and global collaboration to advance cancer treatment.
View Profile
Close
close
Professor Chak-sing Lau
The University of Hong Kong
Professor Chak-sing Lau is the Vice-President (Health) and Dean of the Faculty of Medicine at the University of Hong Kong.
The University of Hong Kong (UHK) is renowned for its outstanding research and significant contributions to the society. Under Professor Lau's leadership, the faculty has made significant advancements in the development of targeted therapies and immunotherapies for liver and lung cancers. In 2024, 32 professors from the Faculty of Medicine were certified as “Highly Cited Researchers”.
View Profile
Close
close
Dr. Mark J. Ratain
The University of Chicago
Dr. Mark J. Ratain serves as the Leon O. Jacobson Professor of Medicine at The University of Chicago. He is also the Director of the University’s Center for Personalized Therapeutics and the Chief Hospital Pharmacologist for University of Chicago Medicine., He is an international leader in phase I clinical trials, pharmacogenetics and clinical trial methodology, and has recently created the new discipline of interventional pharmacoeconomics.
View Profile
Close
close
Co-organiser
Alliance Forum Foundation
More Information
SDGs+Beyond Future Society for Life Week
World Cancer Eradication Summit in EXPO 2025
Cancer is now a common disease for the mankind that threatens the life.
In this program, we will work around the world to eradicate cancer and find a way to free mankind.
Indeed, we will look at the cutting-edge medicine without conventional thoughts, and discuss “What should we do to realize a society in which people can live healthy and brightly until the end of lives?”
-
2025.10.05[Sun]
14:30～16:30
(Venue Open 14:00)
- Theme Weeks Studio
- * Programme times and content are subject to change. Any changes will be announced on this website and via the ticket booking system.
- * The schedule is subject to change depending on the organiser's circumstances.
世界がん撲滅サミット
OTHER PROGRAM
SDGs+Beyond Future Society for Life Week
